HOME

• Web of Science Core Collection, JCR® Impact Factor - 1.607/2019
• JCR® Impact Factor - 1.326/5 years

We are in the process of changing our web address to: www.FarmaciaJournal.com

Untill the end of 2019 the article archive will be moved to the new site, while both websites will be functional.

This website is expected to be terminated at the begining of 2020.

Indexed by:

• Science Citation Index Expanded
• SciVerse Scopus
• Chemical Abstracts Service
• EMBASE
• SCImago Journal&Country Rank
• IPA, British Library, SSCI, A&HCI,
• CPCI-S, CPCI-SSH, BKCI-S, BKCI-SSH, ESCI, CCR-EXPANDED, IC.

ISSN: 0014-8237 (for the Printed Edition)
ISSN: 2065-0019 (for the On-Line Edition)

• FARMACIA publishes original research papers, invited topical reviews and editorial commentaries and news, with emphasis on conceptual novelty and scientific quality. Main research areas are focused on: pharmacology, toxicology, medicinal chemistry, biopharmacy, drug design, drug delivery, personalized medicine, nanostructures, nutraceuticals, biochemistry and biotechnology. Manuscripts submitted to the Journal are only accepted after the peer review precess. The papers should have not been published in any other journal. The recommendations of the Declaration of Helsinki, for humans, and the International guidelines as accepted principles for the use of experimental animals should be followed.

The Editorial Board aimed, from the beginning, to harmonize its publication with the international ones. In this respect, FARMACIA is actively involved in a continuous exchange with pharmaceutical publications worldwide.

.

ANUNT: Document de pozitie pe tema medicamentelor biologice

INTERNATIONAL GOLD STAR AWARD FOR QUALITY
Geneva 2013

Click aici pentru comunicatul de presa.

Click aici pentru inregistrarea video.